Equities
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)6,383.00
  • Today's Change-1.00 / -0.02%
  • Shares traded1.63m
  • 1 Year change+31.99%
  • Beta0.8694
Data delayed at least 20 minutes, as of Nov 21 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1,111,3671,259,726999,759
OPERATING EXPENSES
Cost of revenue total412,650476,251337,680
Selling, general and admin. expenses, total111,91699,583100,754
Depreciation/amortization1,3691,8201,810
Unusual expense(income)5,7586416,342
Other operating expenses, total(28561)63--
Total operating expense672,193726,417577,862
Operating income439,174533,309421,897
Other, net407(2912)(2568)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes443,821531,166419,385
Provision for income taxes118,349156,737116,390
Net income after taxes325,472374,429302,995
Minority interest------
Net income before extra. Items325,472374,429302,995
Total extraordinary items------
Net income325,472374,429302,995
Inc.avail. to common excl. extra. Items325,472374,429302,995
Inc.avail. to common incl. extra. Items325,472374,429302,995
EPS RECONCILIATION
Basic/primary weighted average shares1,6451,6451,644
Basic/primary eps excl. extra items198228184
Basic/primary eps incl. extra items198228184
Dilution adjustment------
Diluted weighted average shares1,6451,6451,645
Diluted eps excl. extra items198228184
Diluted eps incl. extra items198228184
COMMON STOCK DIVIDENDS
DPS - common stock primary issue807876
Gross dividend - common stock131,624128,311124,965
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental815848
SUPPLEMENTAL INCOME
Depreciation, supplemental29,14628,40726,864
Total special items5,7586416,342
NORMALISED INCOME
Normalized income before taxes449,579531,807425,727
Effect of special items on income taxes1751.77275
Income tax excluding impact of special items118,524156,739116,665
Normalized income after tax331,055375,068309,062
Normalized income avail. to common331,055375,068309,062
Basic normalized EPS201228188
Diluted normalized EPS201228188
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.